MRI assessment of hemodynamic effects of angiopoietin-2 overexpression in a brain tumor model
Open Access
- 1 October 2009
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (5) , 488-502
Abstract
Despite treatment efforts, the median survival in patients with glioblastoma multiforme, the most aggressive form of glioma, does not extend beyond 12–15 months. One of the major pathophysiological characteristics of these tumors is their ability to induce active angiogenesis. Thus, based on the lack of efficient therapies, agents that inhibit angiogenesis are particularly attractive as a therapeutic option. However, it has been recently proposed that although specifically targeting vascular endothelial growth factor, the main angiogenic factor, certainly leads to significant tumor regression, it could also be followed by tumor relapses. In this case, angiogenesis is driven by alternate pathways that include other angiogenic factors. One possible strategy to overcome this therapeutic obstacle is to overexpress antivascular factors such as angiopoietin-2 (Ang2). Here, by using MRI and histological analysis, we studied the vascular events involved in glioma growth impairment induced by Ang2 overexpression. Our results show that an increase in Ang2 expression, during the tumor growth, leads to a significant decrease in tumor growth (∼86%) along with an increase in the survival median (∼70%) but does not modify the tumor vascular area or cerebral blood volume. However, tumor Ang2-derived blood vessels display an abnormal, enlarged morphology. We show that the presence of Ang2 leads to an enhancement of tumor perfusion and a decrease in tumor vessel permeability. Based on our MR image evaluations of hemodynamic tumor vessel changes, we propose that Ang2-derived tumor vessels lead to an inadequate oxygenation of the tumor tissue, leading to impairment in tumor growth.Keywords
This publication has 41 references indexed in Scilit:
- A Neurovascular Niche for Neurogenesis after StrokeThe Journal of Neuroscience, 2006
- Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivoProceedings of the National Academy of Sciences, 2002
- Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell UsJNCI: Journal of the National Cancer Institute, 2002
- Abnormalities in the Recirculation Phase of Contrast Agent Bolus Passage in Cerebral Gliomas: Comparison with Relative Blood Volume and Tumor Grade2002
- Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.2001
- Methodology of brain perfusion imagingJournal of Magnetic Resonance Imaging, 2001
- Changes in tumor hypoxia measured with a double hypoxic marker techniqueInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell JunctionsCirculation Research, 2000
- Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathwayOncogene, 2000
- Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1Science, 1999